{"id":"https://openalex.org/W2000700807","doi":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","title":"Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV\u20101\u2010infected patients: potential role in subcutaneous adipocyte apoptosis","display_name":"Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV\u20101\u2010infected patients: potential role in subcutaneous adipocyte apoptosis","alternate_titles":[],"publication_year":2005,"publication_date":"2005-11-25","ids":{"openalex":"https://openalex.org/W2000700807","doi":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","mag":"2000700807","pmid":"https://pubmed.ncbi.nlm.nih.gov/16313254"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2362.2005.01576.x","doi":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","pdf_url":null,"source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000700807"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5072944678","display_name":"Per\u00e9 Domingo","orcid":"https://orcid.org/0000-0003-1138-5770","observed_orcids":["https://orcid.org/0000-0003-1138-5770"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":true,"raw_author_name":"P. Domingo","raw_affiliation_strings":["Department of Internal Medicine (Infectious Diseases Unit), Autonomous University of Barcelona, Barcelona, Spain. pere.domingo@uab.es","Autonomous University of Barcelona, Barcelona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Internal Medicine (Infectious Diseases Unit), Autonomous University of Barcelona, Barcelona, Spain. pere.domingo@uab.es","institution_ids":["https://openalex.org/I123044942"]},{"raw_affiliation_string":"Autonomous University of Barcelona, Barcelona,","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028508664","display_name":"Francesc Vidal","orcid":"https://orcid.org/0000-0002-6692-6186","observed_orcids":["https://orcid.org/0000-0002-6692-6186"]},"institutions":[{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F. Vidal","raw_affiliation_strings":["Rovira i Virgili University, Tarragona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rovira i Virgili University, Tarragona,","institution_ids":["https://openalex.org/I55952717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078917733","display_name":"Joan Carles Domingo","orcid":"https://orcid.org/0000-0002-6356-0836","observed_orcids":["https://orcid.org/0000-0002-6356-0836"]},"institutions":[{"id":"https://openalex.org/I71999127","display_name":"Universitat de Barcelona","ror":"https://ror.org/021018s57","country_code":"ES","type":"education","lineage":["https://openalex.org/I71999127"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. C. Domingo","raw_affiliation_strings":["University of Barcelona, Barcelona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Barcelona, Barcelona,","institution_ids":["https://openalex.org/I71999127"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084781955","display_name":"Sergio Veloso","orcid":"https://orcid.org/0000-0001-7943-1169","observed_orcids":["https://orcid.org/0000-0001-7943-1169"]},"institutions":[{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"S. Veloso","raw_affiliation_strings":["Rovira i Virgili University, Tarragona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rovira i Virgili University, Tarragona,","institution_ids":["https://openalex.org/I55952717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113541913","display_name":"Maria Antonia Sambeat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"M. A. Sambeat","raw_affiliation_strings":["Autonomous University of Barcelona, Barcelona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Autonomous University of Barcelona, Barcelona,","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014511134","display_name":"Ferr\u00e0n Torres","orcid":"https://orcid.org/0000-0002-7355-7913","observed_orcids":["https://orcid.org/0000-0002-7355-7913"]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"F. Torres","raw_affiliation_strings":["Autonomous University of Barcelona, Barcelona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Autonomous University of Barcelona, Barcelona","institution_ids":["https://openalex.org/I123044942"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022286901","display_name":"Juan J. Sirvent","orcid":"https://orcid.org/0000-0002-7486-8916","observed_orcids":["https://orcid.org/0000-0002-7486-8916"]},"institutions":[{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. J. Sirvent","raw_affiliation_strings":["Rovira i Virgili University, Tarragona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rovira i Virgili University, Tarragona,","institution_ids":["https://openalex.org/I55952717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037966759","display_name":"Joan Josep Vendrell","orcid":"https://orcid.org/0000-0002-6994-6115","observed_orcids":["https://orcid.org/0000-0002-6994-6115"]},"institutions":[{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"J. Vendrell","raw_affiliation_strings":["Rovira i Virgili University, Tarragona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rovira i Virgili University, Tarragona,","institution_ids":["https://openalex.org/I55952717"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069925431","display_name":"Xavier Mat\u00edas\u2010Guiu","orcid":"https://orcid.org/0000-0002-7201-6605","observed_orcids":["https://orcid.org/0000-0002-7201-6605"]},"institutions":[{"id":"https://openalex.org/I15766328","display_name":"Universitat de Lleida","ror":"https://ror.org/050c3cw24","country_code":"ES","type":"education","lineage":["https://openalex.org/I15766328"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"X. Matias\u2010Guiu","raw_affiliation_strings":["University of Lleida, Lleida, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Lleida, Lleida, Spain","institution_ids":["https://openalex.org/I15766328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050995269","display_name":"Crist\u00f3bal Richart","orcid":"https://orcid.org/0000-0003-0852-6739","observed_orcids":["https://orcid.org/0000-0003-0852-6739"]},"institutions":[{"id":"https://openalex.org/I55952717","display_name":"Universitat Rovira i Virgili","ror":"https://ror.org/00g5sqv46","country_code":"ES","type":"education","lineage":["https://openalex.org/I55952717"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"C. Richart","raw_affiliation_strings":["Rovira i Virgili University, Tarragona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rovira i Virgili University, Tarragona,","institution_ids":["https://openalex.org/I55952717"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the HIV\u2010FRS Study Group","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123044942","display_name":"Universitat Aut\u00f2noma de Barcelona","ror":"https://ror.org/052g8jq94","country_code":"ES","type":"education","lineage":["https://openalex.org/I123044942"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"on behalf of the HIV\u2010FRS Study Group","raw_affiliation_strings":["Autonomous University of Barcelona, Barcelona,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Autonomous University of Barcelona, Barcelona,","institution_ids":["https://openalex.org/I123044942"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5072944678"],"corresponding_institution_ids":["https://openalex.org/I123044942"],"apc_list":{"value":4100,"currency":"USD","value_usd":4100},"apc_paid":null,"fwci":2.7719,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.89078253,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"35","issue":"12","first_page":"771","last_page":"780"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10528","display_name":"Adipokines, Inflammation, and Metabolic Diseases","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9380000233650208},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9210000038146973},{"id":"https://openalex.org/keywords/soluble-tnf-alpha-receptor","display_name":"soluble TNF-alpha receptor","score":0.8799999952316284},{"id":"https://openalex.org/keywords/indinavir","display_name":"indinavir","score":0.9559999704360962},{"id":"https://openalex.org/keywords/stavudine","display_name":"stavudine","score":0.9520000219345093},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9950000047683716},{"id":"https://openalex.org/keywords/adipocyte-viability","display_name":"adipocyte viability","score":0.7129999995231628},{"id":"https://openalex.org/keywords/tunel-assay","display_name":"TUNEL","score":0.6800000071525574},{"id":"https://openalex.org/keywords/tnf-receptor-1","display_name":"TNF receptor 1","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C196795494","wikidata":"https://www.wikidata.org/wiki/Q1624817","display_name":"TUNEL assay","level":3,"score":0.7099349498748779},{"id":"https://openalex.org/C2776175234","wikidata":"https://www.wikidata.org/wiki/Q357519","display_name":"Adipocyte","level":3,"score":0.6402834057807922},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5192829966545105},{"id":"https://openalex.org/C154113507","wikidata":"https://www.wikidata.org/wiki/Q411149","display_name":"Terminal deoxynucleotidyl transferase","level":4,"score":0.4883984923362732},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.482172429561615},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47410351037979126},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4702916145324707},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4291067123413086},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4217774271965027},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3185300827026367},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.17756199836730957},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.09599867463111877}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008060","descriptor_name":"Lipodystrophy","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008060","descriptor_name":"Lipodystrophy","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008060","descriptor_name":"Lipodystrophy","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013194","descriptor_name":"Staining and Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016022","descriptor_name":"Case-Control Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016475","descriptor_name":"3T3 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017667","descriptor_name":"Adipocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018119","descriptor_name":"Stavudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020287","descriptor_name":"In Situ Nick-End Labeling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047888","descriptor_name":"Receptors, Tumor Necrosis Factor, Type I","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D047889","descriptor_name":"Receptors, Tumor Necrosis Factor, Type II","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2362.2005.01576.x","doi":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2362.2005.01576.x","pdf_url":null,"source":{"id":"https://openalex.org/S153084679","display_name":"European Journal of Clinical Investigation","issn_l":"0014-2972","issn":["0014-2972","1365-2362"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Clinical Investigation","raw_type":"journal-article"},{"id":"pmid:16313254","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16313254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of clinical investigation","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":43,"referenced_works":["https://openalex.org/W163453395","https://openalex.org/W179857658","https://openalex.org/W319470940","https://openalex.org/W1593599243","https://openalex.org/W1879288376","https://openalex.org/W1895081448","https://openalex.org/W1926462303","https://openalex.org/W1977705956","https://openalex.org/W1977725980","https://openalex.org/W1978055778","https://openalex.org/W1980530820","https://openalex.org/W1987723409","https://openalex.org/W1988870963","https://openalex.org/W1999771650","https://openalex.org/W2007315078","https://openalex.org/W2009104414","https://openalex.org/W2019113684","https://openalex.org/W2029047086","https://openalex.org/W2037561994","https://openalex.org/W2044488792","https://openalex.org/W2055406349","https://openalex.org/W2059677823","https://openalex.org/W2067416157","https://openalex.org/W2077488136","https://openalex.org/W2089040602","https://openalex.org/W2095118791","https://openalex.org/W2111648036","https://openalex.org/W2111966641","https://openalex.org/W2112412532","https://openalex.org/W2114291961","https://openalex.org/W2115784485","https://openalex.org/W2133055307","https://openalex.org/W2140295925","https://openalex.org/W2140662416","https://openalex.org/W2155018885","https://openalex.org/W2160234571","https://openalex.org/W2164676747","https://openalex.org/W2165003108","https://openalex.org/W2317583984","https://openalex.org/W2330371438","https://openalex.org/W2560209713","https://openalex.org/W4320578154","https://openalex.org/W7043039266"],"related_works":["https://openalex.org/W1879288376","https://openalex.org/W319470940","https://openalex.org/W2171956461","https://openalex.org/W409517454","https://openalex.org/W2164676747","https://openalex.org/W2443243109","https://openalex.org/W2011513497","https://openalex.org/W2091528060","https://openalex.org/W4320578154"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,44,114],"pathogenesis":[2],"of":[3,12,21,27,61,104,140,166,176,196,243,261],"fat":[4],"redistribution":[5],"syndromes":[6],"(FRS)":[7],"observed":[8,239],"in":[9,36,50,53,65,115,180,211,252,258,263],"the":[10,19,28,49,59,90,109,174,194,241,259],"setting":[11,260],"highly":[13,267],"active":[14,268],"antiretroviral":[15,269],"therapy":[16],"(HAART)":[17],"for":[18,189],"treatment":[20],"HIV-1-infection":[22],"remains":[23],"elusive.":[24],"A":[25],"dysregulation":[26],"tumour":[29],"necrosis":[30],"factor":[31],"alpha":[32],"(TNF-alpha)":[33],"system":[34],"occurs":[35,257],"HIV-infected":[37],"patients":[38,68,76,133,181,265],"with":[39,71,122,134,182,206,215,235,240],"FRS.":[40],"MATERIALS":[41],"AND":[42],"METHODS:":[43],"study":[45],"looked":[46],"at":[47],"both":[48,190],"vivo":[51],"and":[52,58,81,127,151,171,173,183,218,228],"vitro":[54,116],"relationship":[55],"between":[56,163],"TNF-alpha":[57,105,168,197,247],"degree":[60,175],"subcutaneous":[62,141,177,253],"adipocyte":[63,142,178,203,223,230,254],"apoptosis":[64,128,143,179,231],"60":[66,74,82],"HIV-1-infected":[67,75,132,264],"on":[69,77,266],"HAART":[70,78],"FRS,":[72],"another":[73],"without":[79,146,184],"FRS":[80,135,147,185,262],"uninfected":[83,152],"control":[84],"patients.":[85],"Apoptosis":[86],"was":[87,118,158],"assessed":[88,119],"by":[89,108,120,129],"terminal":[91],"deoxynucleotidyl":[92],"transferase":[93],"dUTP":[94],"(deoxyuridine":[95],"5'-triphosphate)-digoxigenin":[96],"Nick":[97],"End":[98],"Labelling":[99],"(TUNEL)":[100],"method.":[101],"Soluble":[102],"receptors":[103,169],"were":[106],"determined":[107],"sandwich":[110],"enzyme":[111],"immunoassay":[112],"technique.":[113],"viability":[117,224],"staining":[121],"3-(4,5-dimethylthiazol-2-yl)-2,5":[123],"diphenyltetrazolium":[124],"bromide":[125],"(MTT)":[126],"TUNEL.":[130],"RESULTS:":[131],"had":[136],"significantly":[137,221],"higher":[138],"degrees":[139],"than":[144],"those":[145],"(P":[148,154,186,225,232],"=":[149,226],"0.0001)":[150,227,234],"controls":[153],"<":[155,187,233],"0.0001).":[156],"There":[157],"a":[159,249],"statistically":[160],"significant":[161,250],"association":[162],"serum":[164],"levels":[165],"soluble":[167],"#1":[170],"#2":[172],"0.0001":[188],"receptors).":[191],"In":[192],"vitro,":[193],"addition":[195,242],"(10":[198],"ng":[199],"mL(-1))":[200],"to":[201,237],"an":[202],"culture":[204],"embedded":[205],"indinavir,":[207],"either":[208],"alone":[209],"or":[210],"clinically":[212],"relevant":[213],"combinations":[214],"stavudine":[216],"(d4T)":[217],"lamivudine":[219],"(3TC),":[220],"decreased":[222],"increased":[229],"respect":[236],"that":[238],"antiretrovirals":[244],"alone.":[245],"CONCLUSIONS:":[246],"plays":[248],"role":[251],"apoptosis,":[255],"which":[256],"therapy.":[270]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000700807","counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
